Graus F, Vogrig A, Muñiz-Castrillo S, Antoine JCG, Desetret V, Dubey D, et al. Updated diagnostic criteria for paraneoplastic neurologic syndromes. Neurol Neuroimmunol Neuroinflamm. 2021;8(4):e1014.

Article  PubMed  PubMed Central  Google Scholar 

Vogrig A, Gigli GL, Segatti S, Corazza E, Marini A, Bernardini A, et al. Epidemiology of paraneoplastic neurological syndromes: a population-based study. J Neurol. 2020;267(1):26–35.

Article  PubMed  CAS  Google Scholar 

Greenlee JE, Brashear HR. Antibodies to cerebellar Purkinje cells in patients with paraneoplastic cerebellar degeneration and ovarian carcinoma. Ann Neurol. 1983;14(6):609–13.

Article  PubMed  CAS  Google Scholar 

Jaeckle KA, Graus F, Houghton A, Cardon-Cardo C, Nielsen SL, Posner JB. Autoimmune response of patients with paraneoplastic cerebellar degeneration to a Purkinje cell cytoplasmic protein antigen. Ann Neurol. 1985;18(5):592–600.

Article  PubMed  CAS  Google Scholar 

Darnell RB, Posner JB. Paraneoplastic syndromes (Contemporary Neurology Series, 79). Oxford University Press; 2011.

Peterson K, Rosenblum MK, Kotanides H, Posner JB. Paraneoplastic cerebellar degeneration I A clinical analysis of 55 anti-Yo antibody-positive patients. Neurol. 1992;42(10):1931–7.

Article  CAS  Google Scholar 

McKeon A, Tracy JA, Pittock SJ, Parisi JE, Klein CJ, Lennon VA. Purkinje cell cytoplasmic autoantibody type 1 accompaniments: the cerebellum and beyond. Arch Neurol. 2011;68(10):1282–9.

Article  PubMed  Google Scholar 

Meglic B, Graus F, Grad A. Anti-Yo-associated paraneoplastic cerebellar degeneration in a man with gastric adenocarcinoma. J Neurol Sci. 2001;185(2):135–8.

Article  PubMed  CAS  Google Scholar 

Goto A, Kusumi M, Wakutani Y, Nakaso K, Kowa H, Nakashima K. Anti-Yo antibody associated paraneoplastic cerebellar degeneration with gastric adenocarcinoma in a male patient: a case report. Rinsho Shinkeigaku. 2006;46(2):144–7.

PubMed  Google Scholar 

Li Y, Liu Y, Jia Y, Jiao S. Anti-Yo-associated paraneoplastic cerebellar degeneration in a man with gastric adenocarcinoma: one case report and literature review. Chin J Neurol. 2020;53(5):368–71.

Google Scholar 

Xia K, Saltzman JR, Carr-Locke DL. Anti-Yo antibody-mediated paraneoplastic cerebellar degeneration in a man with esophageal adenocarcinoma. MedGenMed. 2003;5(3):18.

PubMed  Google Scholar 

Sutton IJ, Fursdon Davis CJ, Esiri MM, Hughes S, Amyes ER, Vincent A. Anti-Yo antibodies and cerebellar degeneration in a man with adenocarcinoma of the esophagus. Ann Neurol. 2001;49(2):253–7.

Article  PubMed  CAS  Google Scholar 

Bruhnding A, Notch D, Beard A. Anti-Yo positive paraneoplastic cerebellar degeneration in the setting of cholangiocarcinoma. J Clin Neurosci. 2017;36:71–2.

Article  PubMed  Google Scholar 

Kim JA, Pinto A, Nucci MR, Lyons JL. Concomitant opsoclonus and ataxia and limbic encephalitis due to dual anti-RI and anti-Yo positive antibodies in uterine carcinosarcoma: a case report. Clin Expe Neuroimmunol. 2015;7(1):75–87.

Article  Google Scholar 

Bhargava A, Bhushan B, Kasundra GM, Shubhakaran K, Pujar GS, Banakar B. Response to abdominal hysterectomy with bilateral salpingo-oophorectomy in postmenopausal woman with anti-Yo antibody mediated paraneoplastic cerebellar degeneration. Ann Indian Acad Neurol. 2014;17(3):355–7.

Article  PubMed  PubMed Central  Google Scholar 

Geomini PM, Dellemijn PL, Bremer GL. Paraneoplastic cerebellar degeneration: neurological symptoms pointing to occult ovarian cancer. Gynecol Obstet Invest. 2001;52(2):145–6.

Article  PubMed  CAS  Google Scholar 

Kato N, Hashida G, Konaka K. Rehabilitation for a patient with anti-Yo antibody-positive paraneoplastic cerebellar degeneration caused by breast cancer: a case report and literature review. Med. 2017;96(44):e8468.

Article  Google Scholar 

Panegyres PK, Graves A. Anti-Yo and anti-glutamic acid decarboxylase antibodies presenting in carcinoma of the uterus with paraneoplastic cerebellar degeneration: a case report. J Med Case Rep. 2012;6:155.

Article  PubMed  PubMed Central  Google Scholar 

Santillan A, Bristow RE. Paraneoplastic cerebellar degeneration in a woman with ovarian cancer. Nat Clin Pract Oncol. 2006;3(2):108–12.

Article  PubMed  Google Scholar 

Chien HJ, Lee CY, Chen LA, Wu CC, Chang CL. Paraneoplastic cerebellar degeneration in a patient with ovarian cancer. Taiwan J Obstet Gynecol. 2015;54(3):313–5.

Article  PubMed  Google Scholar 

Bhardwaj S, Khasani S, Benasher D, et al. Paraneoplastic cerebellar degeneration in nasopharyngeal carcinoma: a unique association. Cerebellum. 2019;18(6):1126–9.

Article  PubMed  CAS  Google Scholar 

Gilmore CP, Elliott I, Auer D, Maddison P. Diffuse cerebellar MR imaging changes in anti-Yo positive paraneoplastic cerebellar degeneration. J Neurol. 2009;257(3):490–1.

Article  PubMed  Google Scholar 

Key RG, Root JC. Anti-Yo mediated paraneoplastic cerebellar degeneration in the context of breast cancer: a case report and literature review. Psychooncol. 2013;22(9):2152–5.

Article  Google Scholar 

Liu S, Tunkel R, Lachmann E, Nagler W. Paraneoplastic cerebellar degeneration as the first evidence of cancer: a case report. Arch Phys Med Rehabil. 2000;81(6):834–6.

Article  PubMed  CAS  Google Scholar 

Selby KJ, Warner J, Klempner S, Konstantinopoulos PA, Hecht JL. Anti-Yo antibody associated with occult fallopian tube carcinoma. Int J Gynecol Pathol. 2011;30(6):536–8.

Article  PubMed  Google Scholar 

Enríquez-Marulanda A, Beltrán-Osorio LD, Escobar LA, Granados AM, Velásquez-Lasprilla F, Orozco JL. Anti-Yo-associated paraneoplastic cerebellar degeneration manifesting as acute cerebellitis with posterior cranial fossa hypertension. World Neurosurg. 2018;112:117–22.

Article  PubMed  Google Scholar 

Hashimoto Y, Komatsu K, Nakagawa T, Matsumoto S. Transient diffusion-weighted imaging hyperintensity of the cerebellar cortex in paraneoplastic cerebellar degeneration. Intern Med. 2019;58(4):619–20.

Article  PubMed  Google Scholar 

Small M, Treilleux I, Couillault C, Pissaloux D, Picard G, Paindavoine S, et al. Genetic alterations and tumor immune attack in Yo paraneoplastic cerebellar degeneration. Acta Neuropathol. 2018;135(4):569–79.

Article  PubMed  CAS  Google Scholar 

The Human Protein Atlas. (2022, May 31). Retrieved July 14, 2022, from http://www.proteinatlas.org.

Rapoport M, van Reekum R, Mayberg H. The role of the cerebellum in cognition and behavior: a selective review. J Neuropsychiatry Clin Neurosci. 2000;12(2):193–8.

Article  PubMed  CAS  Google Scholar 

Verschuuren J, Chuang L, Rosenblum MK, Lieberman F, Pryor A, Posner JB, et al. Inflammatory infiltrates and complete absence of Purkinje cells in anti-Yo-associated paraneoplastic cerebellar degeneration. Acta Neuropathol. 1996;91(5):519–25.

Article  PubMed  CAS  Google Scholar 

Vernino S, O’Neill BP, Marks RS, O’Fallon JR, Kimmel DW. Immunomodulatory treatment trial for paraneoplastic neurological disorders. Neuro Oncol. 2004;6(1):55–62.

Article  PubMed  PubMed Central  Google Scholar 

Herdlevær I, Haugen M, Mazengia K, Totland C, Vedeler C. Paraneoplastic cerebellar degeneration: the importance of including CDR2L as a diagnostic marker. Neurol Neuroimmunol Neuroinflamm. 2021;8(2):e963.

Article  PubMed  PubMed Central  Google Scholar 

Francesc G, Delattre JY, Antoine JC, Dalmau J, Giometto B, Grisold W, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry. 2004;75(8):1135–40.

Article  Google Scholar